UVA Staunton Dialysis is a medicare approved dialysis facility center in Staunton, Virginia and it has 17 dialysis stations. It is located in Staunton City county at 81 Orchard Hill Circle Suite 103, Staunton, VA, 24401. You can reach out to the office of UVA Staunton Dialysis at (540) 280-9248. This dialysis clinic is managed and/or owned by State Owned. UVA Staunton Dialysis has the following ownership type - Non-Profit. It was first certified by medicare in June, 2016. The medicare id for this facility is 493516 and it accepts patients under medicare ESRD program.
| Name | UVA Staunton Dialysis |
|---|---|
| Location | 81 Orchard Hill Circle Suite 103, Staunton, Virginia |
| No. of Dialysis Stations | 17 |
| Medicare ID | 493516 |
| Managed By | State Owned |
| Ownership Type | Non-Profit |
| Late Shifts | No |
| 81 Orchard Hill Circle Suite 103, Staunton, Virginia, 24401 | |
| (540) 280-9248 | |
News Archive
Sun Pharmaceutical Industries Ltd. today announced the expiration of the Tender Offer by Sun's subsidiary, Alkaloida Chemical Company Exclusive Group Ltd. (Alkaloida), to purchase all outstanding Ordinary Shares of Taro Pharmaceutical Industries Ltd. (Taro) for $7.75 per Ordinary Share.
A child's smile is something we take for granted. But muscle dysfunction can turn a simple expression of joy into a challenge. Surface electromyography provides a noninvasive method of sensing muscle activity that can be used for muscle rehabilitation—and to bring a smile to a child's face.
Cells control which genes they express by multiple mechanisms, one of which is the direct modification of DNA with small molecules. Methylation of genes effectively silences them, and excess DNA methylation, particularly of genes that control the cell cycle, is known to promote cancer formation.
A recent case study from North Carolina State University and the University of North Carolina at Chapel Hill demonstrates that, with training, neural control of a powered prosthetic ankle can restore a wide range of abilities, including standing on very challenging surfaces and squatting.
ThromboGenics NV and co-development partner BioInvent International announce today positive results from their Phase II trial of TB-402. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism (VTE) following orthopaedic surgery.
› Verified 5 days ago
| NPI Number | 1407212954 |
| Organization Name | Uva-staunton Dialysis |
| Doing Business As | Rector & Visitors Of The University Of Virginia |
| Address | 81 Orchard Hills Cir Staunton, Virginia, 24401 |
| Phone Number | (540) 280-9248 |
News Archive
Sun Pharmaceutical Industries Ltd. today announced the expiration of the Tender Offer by Sun's subsidiary, Alkaloida Chemical Company Exclusive Group Ltd. (Alkaloida), to purchase all outstanding Ordinary Shares of Taro Pharmaceutical Industries Ltd. (Taro) for $7.75 per Ordinary Share.
A child's smile is something we take for granted. But muscle dysfunction can turn a simple expression of joy into a challenge. Surface electromyography provides a noninvasive method of sensing muscle activity that can be used for muscle rehabilitation—and to bring a smile to a child's face.
Cells control which genes they express by multiple mechanisms, one of which is the direct modification of DNA with small molecules. Methylation of genes effectively silences them, and excess DNA methylation, particularly of genes that control the cell cycle, is known to promote cancer formation.
A recent case study from North Carolina State University and the University of North Carolina at Chapel Hill demonstrates that, with training, neural control of a powered prosthetic ankle can restore a wide range of abilities, including standing on very challenging surfaces and squatting.
ThromboGenics NV and co-development partner BioInvent International announce today positive results from their Phase II trial of TB-402. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism (VTE) following orthopaedic surgery.
› Verified 5 days ago
| Dialysis patients with Hemoglobin data | 30 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 30 |
News Archive
Sun Pharmaceutical Industries Ltd. today announced the expiration of the Tender Offer by Sun's subsidiary, Alkaloida Chemical Company Exclusive Group Ltd. (Alkaloida), to purchase all outstanding Ordinary Shares of Taro Pharmaceutical Industries Ltd. (Taro) for $7.75 per Ordinary Share.
A child's smile is something we take for granted. But muscle dysfunction can turn a simple expression of joy into a challenge. Surface electromyography provides a noninvasive method of sensing muscle activity that can be used for muscle rehabilitation—and to bring a smile to a child's face.
Cells control which genes they express by multiple mechanisms, one of which is the direct modification of DNA with small molecules. Methylation of genes effectively silences them, and excess DNA methylation, particularly of genes that control the cell cycle, is known to promote cancer formation.
A recent case study from North Carolina State University and the University of North Carolina at Chapel Hill demonstrates that, with training, neural control of a powered prosthetic ankle can restore a wide range of abilities, including standing on very challenging surfaces and squatting.
ThromboGenics NV and co-development partner BioInvent International announce today positive results from their Phase II trial of TB-402. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism (VTE) following orthopaedic surgery.
› Verified 5 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 45 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 380 |
| Percentage of adult patients getting regular hemodialysis at the center | 100 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Sun Pharmaceutical Industries Ltd. today announced the expiration of the Tender Offer by Sun's subsidiary, Alkaloida Chemical Company Exclusive Group Ltd. (Alkaloida), to purchase all outstanding Ordinary Shares of Taro Pharmaceutical Industries Ltd. (Taro) for $7.75 per Ordinary Share.
A child's smile is something we take for granted. But muscle dysfunction can turn a simple expression of joy into a challenge. Surface electromyography provides a noninvasive method of sensing muscle activity that can be used for muscle rehabilitation—and to bring a smile to a child's face.
Cells control which genes they express by multiple mechanisms, one of which is the direct modification of DNA with small molecules. Methylation of genes effectively silences them, and excess DNA methylation, particularly of genes that control the cell cycle, is known to promote cancer formation.
A recent case study from North Carolina State University and the University of North Carolina at Chapel Hill demonstrates that, with training, neural control of a powered prosthetic ankle can restore a wide range of abilities, including standing on very challenging surfaces and squatting.
ThromboGenics NV and co-development partner BioInvent International announce today positive results from their Phase II trial of TB-402. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism (VTE) following orthopaedic surgery.
› Verified 5 days ago
| Adult patients getting regular peritoneal dialysis at the center | 14 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 109 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 99 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
Sun Pharmaceutical Industries Ltd. today announced the expiration of the Tender Offer by Sun's subsidiary, Alkaloida Chemical Company Exclusive Group Ltd. (Alkaloida), to purchase all outstanding Ordinary Shares of Taro Pharmaceutical Industries Ltd. (Taro) for $7.75 per Ordinary Share.
A child's smile is something we take for granted. But muscle dysfunction can turn a simple expression of joy into a challenge. Surface electromyography provides a noninvasive method of sensing muscle activity that can be used for muscle rehabilitation—and to bring a smile to a child's face.
Cells control which genes they express by multiple mechanisms, one of which is the direct modification of DNA with small molecules. Methylation of genes effectively silences them, and excess DNA methylation, particularly of genes that control the cell cycle, is known to promote cancer formation.
A recent case study from North Carolina State University and the University of North Carolina at Chapel Hill demonstrates that, with training, neural control of a powered prosthetic ankle can restore a wide range of abilities, including standing on very challenging surfaces and squatting.
ThromboGenics NV and co-development partner BioInvent International announce today positive results from their Phase II trial of TB-402. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism (VTE) following orthopaedic surgery.
› Verified 5 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at UVA Staunton Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 54 |
| Hypercalcemia patient months | 494 |
| Patients with Serumphosphor | 64 |
| Patients with Serumphosphor less than 3.5 mg/dL | 7 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 26 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 27 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 29 |
| Patients with Serumphosphor greater than 7 mg/dL | 11 |
News Archive
Sun Pharmaceutical Industries Ltd. today announced the expiration of the Tender Offer by Sun's subsidiary, Alkaloida Chemical Company Exclusive Group Ltd. (Alkaloida), to purchase all outstanding Ordinary Shares of Taro Pharmaceutical Industries Ltd. (Taro) for $7.75 per Ordinary Share.
A child's smile is something we take for granted. But muscle dysfunction can turn a simple expression of joy into a challenge. Surface electromyography provides a noninvasive method of sensing muscle activity that can be used for muscle rehabilitation—and to bring a smile to a child's face.
Cells control which genes they express by multiple mechanisms, one of which is the direct modification of DNA with small molecules. Methylation of genes effectively silences them, and excess DNA methylation, particularly of genes that control the cell cycle, is known to promote cancer formation.
A recent case study from North Carolina State University and the University of North Carolina at Chapel Hill demonstrates that, with training, neural control of a powered prosthetic ankle can restore a wide range of abilities, including standing on very challenging surfaces and squatting.
ThromboGenics NV and co-development partner BioInvent International announce today positive results from their Phase II trial of TB-402. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism (VTE) following orthopaedic surgery.
› Verified 5 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 46 |
| Patient months included in arterial venous fistula and catheter summaries | 338 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 72 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 12 |
News Archive
Sun Pharmaceutical Industries Ltd. today announced the expiration of the Tender Offer by Sun's subsidiary, Alkaloida Chemical Company Exclusive Group Ltd. (Alkaloida), to purchase all outstanding Ordinary Shares of Taro Pharmaceutical Industries Ltd. (Taro) for $7.75 per Ordinary Share.
A child's smile is something we take for granted. But muscle dysfunction can turn a simple expression of joy into a challenge. Surface electromyography provides a noninvasive method of sensing muscle activity that can be used for muscle rehabilitation—and to bring a smile to a child's face.
Cells control which genes they express by multiple mechanisms, one of which is the direct modification of DNA with small molecules. Methylation of genes effectively silences them, and excess DNA methylation, particularly of genes that control the cell cycle, is known to promote cancer formation.
A recent case study from North Carolina State University and the University of North Carolina at Chapel Hill demonstrates that, with training, neural control of a powered prosthetic ankle can restore a wide range of abilities, including standing on very challenging surfaces and squatting.
ThromboGenics NV and co-development partner BioInvent International announce today positive results from their Phase II trial of TB-402. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism (VTE) following orthopaedic surgery.
› Verified 5 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 33 |
| Hospitalization Rate in facility | 198.8 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 515.7 |
| Hospitalization Rate: Lower Confidence Limit | 82.6 |
News Archive
Sun Pharmaceutical Industries Ltd. today announced the expiration of the Tender Offer by Sun's subsidiary, Alkaloida Chemical Company Exclusive Group Ltd. (Alkaloida), to purchase all outstanding Ordinary Shares of Taro Pharmaceutical Industries Ltd. (Taro) for $7.75 per Ordinary Share.
A child's smile is something we take for granted. But muscle dysfunction can turn a simple expression of joy into a challenge. Surface electromyography provides a noninvasive method of sensing muscle activity that can be used for muscle rehabilitation—and to bring a smile to a child's face.
Cells control which genes they express by multiple mechanisms, one of which is the direct modification of DNA with small molecules. Methylation of genes effectively silences them, and excess DNA methylation, particularly of genes that control the cell cycle, is known to promote cancer formation.
A recent case study from North Carolina State University and the University of North Carolina at Chapel Hill demonstrates that, with training, neural control of a powered prosthetic ankle can restore a wide range of abilities, including standing on very challenging surfaces and squatting.
ThromboGenics NV and co-development partner BioInvent International announce today positive results from their Phase II trial of TB-402. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism (VTE) following orthopaedic surgery.
› Verified 5 days ago
The rate of readmission show you whether patients who were being treated regularly at UVA Staunton Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 21.7 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 40.6 |
| Readmission Rate: Lower Confidence Limit | 8.8 |
News Archive
Sun Pharmaceutical Industries Ltd. today announced the expiration of the Tender Offer by Sun's subsidiary, Alkaloida Chemical Company Exclusive Group Ltd. (Alkaloida), to purchase all outstanding Ordinary Shares of Taro Pharmaceutical Industries Ltd. (Taro) for $7.75 per Ordinary Share.
A child's smile is something we take for granted. But muscle dysfunction can turn a simple expression of joy into a challenge. Surface electromyography provides a noninvasive method of sensing muscle activity that can be used for muscle rehabilitation—and to bring a smile to a child's face.
Cells control which genes they express by multiple mechanisms, one of which is the direct modification of DNA with small molecules. Methylation of genes effectively silences them, and excess DNA methylation, particularly of genes that control the cell cycle, is known to promote cancer formation.
A recent case study from North Carolina State University and the University of North Carolina at Chapel Hill demonstrates that, with training, neural control of a powered prosthetic ankle can restore a wide range of abilities, including standing on very challenging surfaces and squatting.
ThromboGenics NV and co-development partner BioInvent International announce today positive results from their Phase II trial of TB-402. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism (VTE) following orthopaedic surgery.
› Verified 5 days ago